Deca-250

Product Details:

Nandrolone decanoate is approved in the United States specifically for the treatment of anemia of chronic kidney disease and in the United Kingdom specifically for the treatment of osteoporosis in postmenopausal women.
In Australia, it is approved specifically for the treatment of kidney failure, chronic kidney disease, anemia of kidney failure, aplastic anemia, osteoporosis in women in whom estrogens are contraindicated, inoperable breast cancer, and for patients on long-term corticosteroid therapy.